Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enthesitis Assessment with Anti-TNF in Spondyloarthritis
NCT04953871Phase 4Completed
- Start
- Jan 2017
- Primary completion
- Sep 2017
01
Overview
Phase 4, open-label, single-arm trial in spondyloarthritis (SpA). Primary endpoint: Change from ultrasonographic enthesitis score at 3 months. Started Jan 2017; status: completed.
02
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on NCT04953871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04953871.